Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
Schattenfroh
N
N
Chirurgische Klinik, Universitätsklinikums Rudolf Virchow, Freie Universität Berlin, Germany.
Lange
D
D
Bechstein
W O
WO
Blumhardt
G
G
Lohmann
R
R
Neuhaus
P
P
D000206:Actuarial Analysis; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008107:Liver Diseases / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D011184:Postoperative Period; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine